Promoted Content

Promoted Content

All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Approved Neurology Drugs in Clinical Development in SOUTH AFRICA

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Aspen Pharmacare Holdings

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

South Africa

Contact Supplier

Mexico Health Summit

Participation Not Confirmed

Update your events

Sandoz completes acquisition of Aspen’s Japanese operations, strengthening its position in world’s third largest market for generics and...

Contact the Supplier

Lead Product(s): Lidocaine Hydrochloride

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Sandoz B2B

Deal Size: $440.0 million Upfront Cash: $330.0 million

Deal Type: Acquisition January 31, 2020

Details:

The acquisition strengthens Sandoz’s presence in the hospital channel by complementing the broad Sandoz portfolio and pipeline of hospital generic and biosimilar products in Japan.